Cleveland BioLabs Stock News

Gainers Cohen & Company Inc. (NYSE: COHN) shares climbed 27.8% to close at $5.11 on Thursday. The Israeli company posted a Q4 profit of $0.56 per share, versus a year-ago...

The COVID-19 outbreak has proved to be a catalyst for biotechs. Some issues that were wallowing in penny stock territory have posted stratospheric gains in the wake of efforts to...

Cohen & Company (NYSEMKT:COHN) +105% on Q4 results.Can-Fite BioPharma (NYSEMKT:CANF) +42% on collaboration to evaluate Piclidenoson for the potential treatment of coronavirus infection.iBio (NYSEM

Gainers Cellect Biotechnology Ltd. (NASDAQ: APOP) shares jumped 45% to close at $3.03 on Wednesday. Cellect Biotechnology and Canndoc Ltd. agreed to enter into strategic pharma...

Below are companies that have announced plans to develop either vaccines or therapies for COVID-19. Again, some are more credible than others.Vaccines: Sanofi (SNY -1.5%), iBio (IBIO -10.2%), Vaxart (

Spherix (NASDAQ:SPEX) -25%.Dynatronics (NASDAQ:DYNT) -22%.China Pharma Holdings (NYSEMKT:CPHI) -19%.Co-Diagnostics (NASDAQ:CODX) -17%.Tilray (NASDAQ:TLRY) -14% on Q4 earnings.Cleveland BioLabs (NAS

Gainers Stealth BioTherapeutics, Inc. (NASDAQ: MITO) shares surged 74.2% to $3.31 during Tuesday's pre-market session. According to the most recent rating by H.C....

It took a viral outbreak to stall the market's bull run. The U.S. market is in correction territory, with two of the three major averages having pulled back more than 10% from their recent peaks. The

Dynatronics (NASDAQ:DYNT) +224%.Altimmune (NASDAQ:ALT) +143% on completing first development milestone toward a single-dose intranasal COVID-19 vaccine.Allied Healthcare Products (NASDAQ:AHPI) +103%

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 27) Global Cord Blood Corp (NYSE: CO ) Cleveland BioLa